{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:06:48Z","timestamp":1707523608533},"reference-count":13,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,4,25]]},"DOI":"10.7759\/cureus.24470","type":"journal-article","created":{"date-parts":[[2022,4,25]],"date-time":"2022-04-25T15:41:34Z","timestamp":1650901294000},"source":"Crossref","is-referenced-by-count":1,"title":["Disease Severity and Response to Induction Therapy in Hispanic Patients With Antineutrophilic Cytoplasmic Autoantibody-Associated Vasculitis-Related Diffuse Alveolar Hemorrhage"],"prefix":"10.7759","author":[{"given":"Christine E","family":"Loftis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emilia C","family":"Dulgheru","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosa","family":"White","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-eular.5494","article-title":"Ab0565 Diffuse alveolar hemorrhage, diagnosis, treatment and 3-year prognosis in a group of 32 cases of tertiary centre","volume":"75","author":"Bradna P","year":"2016","unstructured":"Bradna P, Manak J, Soukup T, Toms J, Kodeda M. Ab0565 Diffuse alveolar hemorrhage, diagnosis, treatment and 3-year prognosis in a group of 32 cases of tertiary centre. Ann Rheum Dis. 2016, 75:1098. 10.1136\/annrheumdis-2016-eular.5494","journal-title":"Ann Rheum Dis"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00075309","article-title":"Diffuse alveolar haemorrhage: factors associated with in-hospital and long-term mortality","volume":"35","author":"de Prost N","year":"2010","unstructured":"de Prost N, Parrot A, Picard C, Ancel PY, Mayaud C, Fartoukh M, Cadranel J. Diffuse alveolar haemorrhage: factors associated with in-hospital and long-term mortality. Eur Respir J. 2010, 35:1303-11. 10.1183\/09031936.00075309","journal-title":"Eur Respir J"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-014-2617-z","article-title":"ANCA-associated vasculitis in Hispanic Americans: an unrecognized severity","volume":"34","author":"Sreih AG","year":"2015","unstructured":"Sreih AG, Mandhadi R, Aldaghlawi F, Khan A, Irshad V, Finn K, Block JA. ANCA-associated vasculitis in Hispanic Americans: an unrecognized severity. Clin Rheumatol. 2015, 34:943-8. 10.1007\/s10067-014-2617-z","journal-title":"Clin Rheumatol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kez062.046","article-title":"272. Hispanic American patients with ANCA-associated vasculitis and diffuse alveolar hemorrhage respond comparably to induction therapy","volume":"58","author":"Singh S","year":"2019","unstructured":"Singh S, Quismorio F, Ortiz E. 272. Hispanic American patients with ANCA-associated vasculitis and diffuse alveolar hemorrhage respond comparably to induction therapy. Rheumatology. 2019, 58:10.1093\/rheumatology\/kez062.046","journal-title":"Rheumatology"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/art.37715","article-title":"2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides","volume":"65","author":"Jennette JC","year":"2013","unstructured":"Jennette JC, Falk RJ, Bacon PA, et al.. 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum. 2013, 65:1-11. 10.1002\/art.37715","journal-title":"Arthritis Rheum"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197112302852701","article-title":"Effect of cyclophosphamide upon the immune response in Wegener's granulomatosis","volume":"285","author":"Fauci AS","year":"1971","unstructured":"Fauci AS, Wolff SM, Johnson JS. Effect of cyclophosphamide upon the immune response in Wegener's granulomatosis. N Engl J Med. 1971, 285:1493-6. 10.1056\/NEJM197112302852701","journal-title":"N Engl J Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2011-200477","article-title":"Pulse versus daily oral cyclophosphamide for induction of remission in ANCA-associated vasculitis: long-term follow-up","volume":"71","author":"Harper L","year":"2012","unstructured":"Harper L, Morgan MD, Walsh M, et al.. Pulse versus daily oral cyclophosphamide for induction of remission in ANCA-associated vasculitis: long-term follow-up. Ann Rheum Dis. 2012, 71:955-60. 10.1136\/annrheumdis-2011-200477","journal-title":"Ann Rheum Dis"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0909905","article-title":"Rituximab versus cyclophosphamide for ANCA-associated vasculitis","volume":"363","author":"Stone JH","year":"2010","unstructured":"Stone JH, Merkel PA, Spiera R, et al.. Rituximab versus cyclophosphamide for ANCA-associated vasculitis. N Engl J Med. 2010, 363:221-32. 10.1056\/NEJMoa0909905","journal-title":"N Engl J Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-209133","article-title":"EULAR\/ERA-EDTA recommendations for the management of ANCA-associated vasculitis","volume":"75","author":"Yates M","year":"2016","unstructured":"Yates M, Watts RA, Bajema IM, et al.. EULAR\/ERA-EDTA recommendations for the management of ANCA-associated vasculitis. Ann Rheum Dis. 2016, 75:1583-94. 10.1136\/annrheumdis-2016-209133","journal-title":"Ann Rheum Dis"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1803537","article-title":"Plasma exchange and glucocorticoids in severe ANCA-associated vasculitis","volume":"382","author":"Walsh M","year":"2020","unstructured":"Walsh M, Merkel PA, Peh CA, et al.. Plasma exchange and glucocorticoids in severe ANCA-associated vasculitis. N Engl J Med. 2020, 382:622-31. 10.1056\/NEJMoa1803537","journal-title":"N Engl J Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1002\/art.41773","article-title":"2021 American College of Rheumatology\/Vasculitis Foundation Guideline for the management of antineutrophil cytoplasmic antibody-associated vasculitis","volume":"73","author":"Chung SA","year":"2021","unstructured":"Chung SA, Langford CA, Maz M, et al.. 2021 American College of Rheumatology\/Vasculitis Foundation Guideline for the management of antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheumatol. 2021, 73:1366-83. 10.1002\/art.41773","journal-title":"Arthritis Rheumatol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(200002)43:2<405::AID-ANR22>3.0.CO;2-5","article-title":"Drug-associated antineutrophil cytoplasmic antibody-positive vasculitis: prevalence among patients with high titers of antimyeloperoxidase antibodies","volume":"43","author":"Choi HK","year":"2000","unstructured":"Choi HK, Merkel PA, Walker AM, Niles JL. Drug-associated antineutrophil cytoplasmic antibody-positive vasculitis: prevalence among patients with high titers of antimyeloperoxidase antibodies. Arthritis Rheum. 2000, 43:405-13. 10.1002\/1529-0131(200002)43:2&lt;405::AID-ANR22&gt;3.0.CO;2-5","journal-title":"Arthritis Rheum"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-021-05916-z","article-title":"ANCA-associated vasculitis in Caucasian and Hispanics of the Inland Empire of Southern California","volume":"41","author":"Lee S","year":"2022","unstructured":"Lee S, Injean P, Tran P, Panikkath LS, Salto L, Downey C. ANCA-associated vasculitis in Caucasian and Hispanics of the Inland Empire of Southern California. Clin Rheumatol. 2022, 41:549-56. 10.1007\/s10067-021-05916-z","journal-title":"Clin Rheumatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/95121-disease-severity-and-response-to-induction-therapy-in-hispanic-patients-with-antineutrophilic-cytoplasmic-autoantibody-associated-vasculitis-related-diffuse-alveolar-hemorrhage","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:37:21Z","timestamp":1707507441000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/95121-disease-severity-and-response-to-induction-therapy-in-hispanic-patients-with-antineutrophilic-cytoplasmic-autoantibody-associated-vasculitis-related-diffuse-alveolar-hemorrhage"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,25]]},"references-count":13,"URL":"https:\/\/doi.org\/10.7759\/cureus.24470","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4,25]]}}}